16th international conference on Campylobacter, Helicobacter and related organism
第十六届弯曲杆菌、螺杆菌及相关生物国际会议
基本信息
- 批准号:8204251
- 负责人:
- 金额:$ 1.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntibiotic ResistanceAreaAwardBacterial InfectionsBioinformaticsBiologicalBiologyCampylobacterCampylobacter infectionCampylobacter jejuniClinical ManagementCollaborationsCommunicationDataDeveloped CountriesDeveloping CountriesDevelopmentDiarrheaDisciplineDiseaseDisease OutbreaksEducational workshopEnvironmentEpidemiologistEpidemiologyEvolutionFood SafetyFosteringFunctional disorderFundingGastritisGenomicsGlycobiologyGoalsGrantGuillain-Barré SyndromeHealthHealth FoodHelicobacterHelicobacter pyloriHumanImmune responseImmunologyInfectionInternationalInterventionInvestigationJapanKnowledgeMarshalMedicineMethodsMolecularNamesNational Institute of Allergy and Infectious DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesNatural HistoryNobel PrizeOrganismOrganism StrainsPathogenesisPeptic UlcerPreventionProcessProteomicsPublic HealthResearchResearch PersonnelResourcesRobin birdScientistSourceStandardizationStomach CarcinomaStudentsTranslatingTravelUpdateVaccinesVeterinariansWorkanimal ecologyantimicrobialauthoritycomparative genomicsdata exchangefascinategastrointestinalgastrointestinal infectionhuman ecologyimprovedinterestmeetingsmicrobialnext generationnovelpathogenposterspreventrepositoryresistant strainresponsesurveillance strategysymposiumvaccine development
项目摘要
DESCRIPTION (provided by applicant): We propose to host the 16th International Workshop on Campylobacter, Helicobacter and Related Organisms (CHRO) from August 28 - September 1, 2011 in Vancouver. Over the past 25 years, our meetings have been held around the world with the world's leading authorities in the field. This biennial workshop, started in 1981, is an international forum dedicated to enhancing our knowledge of this fascinating group of bacterial pathogens. Campylobacter jejuni is now firmly established as a major cause of bacterial diarrhea in both developed and developing countries. C. jejuni is also one of the major causes of the Guillain-Barre syndrome and continues attracting intense investigation worldwide. Genomic/proteomic/glycomic research on Campylobacter has made important strides on understanding disease pathogenesis and biology and the organism. At the 2nd workshop in Brussels in 1983, Helicobacter pylori (then named Campylobacter pylori) was introduced to the world and the microbiological revolution of gastroduodenal disease began. The association of H. pylori with gastritis, peptic ulcers and gastric carcinoma is now universally recognized. An understanding of the disease process involving H. pylori and hopefully, the means to prevent or control appears to be within reach as a great many scientists and clinicians are striving towards this end. In recognition of the importance of H. pylori, Barry Marshall and Robin Warren were awarded the Nobel Prize in Medicine in 2005 for their discoveries and Barry Marshall remains very active with CHRO meetings and gave a keynote address at the past CHRO meeting in Niigata, Japan in 2009. CHRO meetings have, and continue to be, the major venue for presenting research findings on Campylobacter and Helicobacter. The goals of this conference are 1) to gather junior and senior investigators from around the world who specialize in areas encompassing all aspects of disease due to Campylobacter, Helicobacter and related organisms. These areas include microbial pathogenesis, genomics/proteomics/glycomics, immunology of infections, gastrointestinal pathophysiology, clinical management, public health, food safety, and human and animal ecology; 2) present overviews and updates in these diverse areas by keynote speakers who are experts in their field both inside the field and leading figures in pathogenesis; 3) present the latest results form investigators in these diverse areas in poster sessions and short invited talks; 4) foster new collaborative multi-disciplinary interactions to address pressing questions of pathogenesis, prevention and treatment of diseases due to Campylobacter and Helicobacter and 5) foster and encourage young scientists from different areas of the world to become actively involved in research on Campylobacter and Helicobacter. Funds will be provided as travel grants to students and junior researchers to accomplish this. CHRO meetings address many areas of interest to NIAID as well as NIDDK and NCI. The CHRO meetings focus on understanding the natural history, pathogenesis, and host and immunological responses to infection by Campylobacter and Helicobacter. CHRO is a major venue for presenting new work on developing vaccines for these infections. Finally, genomics/proteomic/glycomic analysis of these gastrointestinal pathogens are a new and important area of research presented at CHRO meetings that contribute to our understanding of the pathogenesis of infections.
PUBLIC HEALTH RELEVANCE: Project Narrative Campylobacter and Helicobacter are the cause of millions of infections worldwide and cause significant morbidity in both resource -rich and resource-challenged nations. The 16th Workshop of Campylobacter, Helicobacter and Related Organisms (CHRO2011) will provide a forum for students, junior and experienced researchers to present new research and discuss approaches that are aimed in reducing the burden of these infections in humans.
描述(由申请人提供):我们提议于2011年8月28日至9月1日在温哥华举办第16届弯曲杆菌、螺杆菌及相关生物国际研讨会(CHRO)。在过去的 25 年里,我们在世界各地与该领域的世界领先权威人士举行了会议。这个两年一度的研讨会始于 1981 年,是一个国际论坛,致力于增强我们对这一令人着迷的细菌病原体的了解。空肠弯曲菌现已被确定为发达国家和发展中国家细菌性腹泻的主要原因。空肠弯曲菌也是格林-巴利综合征的主要原因之一,并继续引起全世界的密切关注。弯曲杆菌的基因组/蛋白质组/糖组学研究在了解疾病发病机制以及生物学和生物体方面取得了重要进展。 1983年在布鲁塞尔举行的第二届研讨会上,幽门螺杆菌(当时命名为幽门弯曲杆菌)被引入世界,胃十二指肠疾病的微生物革命开始了。幽门螺杆菌与胃炎、消化性溃疡和胃癌的关联现已得到普遍认可。了解幽门螺杆菌相关的疾病过程,并希望找到预防或控制的方法,因为许多科学家和临床医生正在为此努力。为了认识到幽门螺杆菌的重要性,巴里·马歇尔 (Barry Marshall) 和罗宾·沃伦 (Robin Warren) 因其发现而荣获 2005 年诺贝尔医学奖,巴里·马歇尔 (Barry Marshall) 仍然非常积极参与 CHRO 会议,并在日本新泻举行的上届 CHRO 会议上发表了主题演讲2009 年。CHRO 会议已经并将继续成为展示弯曲杆菌和螺杆菌研究成果的主要场所。本次会议的目标是 1) 聚集来自世界各地的初级和高级研究人员,他们专门研究弯曲杆菌、螺杆菌和相关生物引起的疾病的各个方面。这些领域包括微生物发病机制、基因组学/蛋白质组学/糖组学、感染免疫学、胃肠道病理生理学、临床管理、公共卫生、食品安全以及人类和动物生态学; 2) 由主讲人介绍这些不同领域的概述和最新动态,他们是各自领域的专家和发病机制的领军人物; 3)在海报会议和简短的邀请演讲中展示这些不同领域的研究人员的最新成果; 4) 促进新的多学科协作互动,解决弯曲杆菌和螺杆菌引起的疾病的发病机制、预防和治疗等紧迫问题;5) 培养和鼓励来自世界不同地区的年轻科学家积极参与弯曲杆菌和螺杆菌的研究。资金将作为旅行补助金提供给学生和初级研究人员以实现这一目标。 CHRO 会议涉及 NIAID 以及 NIDDK 和 NCI 感兴趣的许多领域。 CHRO 会议的重点是了解弯曲杆菌和螺杆菌感染的自然史、发病机制以及宿主和免疫反应。 CHRO 是展示针对这些感染开发疫苗的新工作的主要场所。最后,这些胃肠道病原体的基因组学/蛋白质组学/糖组学分析是 CHRO 会议上提出的一个新的重要研究领域,有助于我们了解感染的发病机制。
公共卫生相关性:项目叙述弯曲杆菌和螺杆菌是全世界数以百万计的感染的原因,并在资源丰富和资源匮乏的国家造成显着的发病率。第 16 届弯曲杆菌、螺杆菌及相关生物研讨会 (CHRO2011) 将为学生、初级和经验丰富的研究人员提供一个论坛,展示新的研究并讨论旨在减轻人类这些感染负担的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRVING NACHAMKIN其他文献
IRVING NACHAMKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRVING NACHAMKIN', 18)}}的其他基金
Development of a novel antibody therapy for clostridium difficile infection
开发针对艰难梭菌感染的新型抗体疗法
- 批准号:
7962084 - 财政年份:2010
- 资助金额:
$ 1.2万 - 项目类别:
Development of a novel antibody therapy for clostridium difficile infection
开发针对艰难梭菌感染的新型抗体疗法
- 批准号:
8136259 - 财政年份:2010
- 资助金额:
$ 1.2万 - 项目类别:
13th International Campylobacter/Helicobacter workshop
第十三届国际弯曲菌/螺杆菌研讨会
- 批准号:
7058473 - 财政年份:2005
- 资助金额:
$ 1.2万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights
探究人类抗葡萄球菌抗体反应以获得金黄色葡萄球菌疫苗见解
- 批准号:
10826874 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Metabolic determinants of Staphylococcus aureus skin colonization
金黄色葡萄球菌皮肤定植的代谢决定因素
- 批准号:
10749745 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Development of a model of Gonococcal conjunctivitis for vaccine evaluations
开发用于疫苗评估的淋菌性结膜炎模型
- 批准号:
10740430 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
- 批准号:
10693593 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别: